Focused Ultrasound Therapy to Augment Antigen Presentation and Immune-Specificity of Checkpoint Inhibitor Therapy With Pembrolizumab in Metastatic Breast Cancer
Phase of Trial: Phase I
Latest Information Update: 01 Feb 2018
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Advanced breast cancer
- Focus Pharmacodynamics
- Acronyms Breast-48
- 31 Aug 2018 Biomarkers information updated
- 25 Sep 2017 Status changed from not yet recruiting to recruiting.
- 01 Sep 2017 Planned initiation date changed from 25 Aug 2017 to 19 Oct 2017.